Experimental group 2:hydroxysafflor yellow A (HSYA) injection 50mg

2 trials

Sponsors

Guangdong Hospital of traditional Chinese Medicine

Conditions

Acute atherosclerotic thrombotic cerebral infarction

Phase 2

A randomized, double-blinded, parallel-controlled, dose exploratory, multicentered-phase II clinical trial for the safety and effectiveness of hydroxysafflor yellow A (HSYA) injection in the treatment of&

Active, not recruitingITMCTR2000002982

Guangdong Hospital of traditional Chinese MedicineAcute atherosclerotic thrombotic cerebral infarction

Start: 2013-07-20Updated: 2023-02-20

A randomized, double-blinded, parallel-controlled, dose exploratory, multicentered-phase II clinical trial for the safety and effectiveness of hydroxysafflor yellow A (HSYA) injection in the treatment of acute atherosclerotic thrombotic cerebral infarction (stroke, meridional and collateral stroke and congestion block collateral sympt

Active, not recruitingChiCTR2000029608

Guangdong Hospital of traditional Chinese MedicineAcute atherosclerotic thrombotic cerebral infarction

Start: 2013-07-20Updated: 2020-02-10